Guardant Health, Inc.
GHNASDAQHealthcare● Active
$128.46
+$2.85(+2.27%)
Market Cap$17.0B
P/E Ratio—
52W High$133.97
52W Low$40.35
Guardant Health, Inc. (GH) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · GH · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.98B | $0.74B | $0.56B | $0.45B | $0.37B |
| Cost of Revenue | $0.35B | $0.29B | $0.23B | $0.16B | $0.12B |
| Gross Profit | $0.63B | $0.45B | $0.34B | $0.29B | $0.25B |
| Gross Margin %(computed) | 64.46% | 60.79% | 59.74% | 65.23% | 67.11% |
| Operating Expenses | |||||
| R&D Expenses | $0.36B | $0.35B | $0.37B | $0.37B | $0.26B |
| G&A Expenses | $0.21B | $0.18B | $0.16B | $0.16B | $0.21B |
| Total Operating Expenses | $1.07B | $0.89B | $0.90B | $0.84B | $0.66B |
| Operating Income | ($0.44B) | ($0.44B) | ($0.56B) | ($0.54B) | ($0.41B) |
| Operating Margin %(computed) | -44.43% | -60.02% | -100.14% | -121.10% | -110.00% |
| Interest Income | $0.03B | $0.05B | $0.04B | $0.01B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.42B) | ($0.44B) | ($0.48B) | ($0.65B) | ($0.38B) |
| Income Tax Expense | ($0.00B) | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.42B) | ($0.44B) | ($0.48B) | ($0.65B) | ($0.41B) |
| Net Margin %(computed) | -42.39% | -59.05% | -85.02% | -145.61% | -108.57% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.32 | $-3.56 | $-4.28 | $-6.41 | $-3.80 |
| Wtd Avg Shares | 0.13B | 0.12B | 0.11B | 0.10B | 0.10B |
| EBITDA | ($0.37B) | ($0.39B) | ($0.43B) | ($0.61B) | ($0.36B) |
| EBITDA Margin %(computed) | -38.08% | -52.79% | -76.83% | -136.79% | -96.24% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Guardant Health, Inc. data
About Guardant Health, Inc. (GH) Income Statement
Guardant Health, Inc. (GH) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, GH reported revenue of $0.98B, gross profit of $0.63B (gross margin 64.46%), and net income of ($0.42B) — a net profit margin of -42.39%.
Frequently asked questions
GH · 4 questionsGuardant Health, Inc. (GH) reported revenue of $0.98B for 2025, up 32.9% year-over-year.
GH revenueGH salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08